The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies

Cited by (211)

Items 201–211 of 211

  1. Nucleic acid-encoded antibody gene transfer-next generation of antibody therapies
    Kaikai Yu, Geng Xiao, Baichuan Chen, Na Xu, Wensen Liu · 2025 · Drug Delivery
  2. A cocktail of SARS-CoV-2 spike stem helix domain and receptor binding domain human monoclonal antibodies prevent the emerge of viral escape mutants
    Yao Ma, Chengjin Ye, Michael S. Piepenbrink, Sara Hussein Mahmoud, Anastasija Čupić, Esmeralda Gracián-Castro, Nathaniel D. Jackson, Mahmoud Bayoumi, Alvaro Souto Padron, Adolfo García‐Sastre et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Targeting emerging viruses with phage display-driven engineered antibodies: Bridging molecular design and clinical application
    Ah Hyun Cho, Su Yeon Cho, Soohyun Kim, Sukmook Lee · 2025 · Molecular Aspects of Medicine
  4. Additional file 2 of Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study
    Scaglione, Vincenzo, Salvatore Rotundo, Nadia Marascio, Carmela De Marco, Rosaria Lionello, Claudia Veneziano, Lavinia Berardelli, Quirino, Angela, Vincenzo Olivadese, Francesca Serapide et al. · 2022 · Figshare
  5. Additional file 1 of Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study
    Scaglione, Vincenzo, Salvatore Rotundo, Nadia Marascio, Carmela De Marco, Rosaria Lionello, Claudia Veneziano, Lavinia Berardelli, Quirino, Angela, Vincenzo Olivadese, Francesca Serapide et al. · 2022 · Figshare
  6. Innovative Diagnostic and Therapeutic Methods in Clinical Medicine: A Systematic Review
    Ivanna Pavlyshyn, Andriana Bundz · 2026 · Futurity Medicine.
  7. Insights into the structural differences between homo- and heterodimers enriched from a cocktail of monoclonal antibodies against SARS-CoV-2
    Jennifer B. Nguyen, Sophia Liu, Yuetian Yan, Deepanshu Choudhary, Zachary R. Oberholtzer, Yi Zhou, Donna J. Skow, Mushhood Sheikh, Cristinel Sandu, Shunhai Wang et al. · 2026 · Scientific Reports
  8. Mining antibody functionality via AI-guided structural landscape profiling
    Stanislav S. Terekhov, Nikita V. Ivanisenko, Nan Zhang, Yuliana A. Mokrushina, Dmitry E. Nolde, Yakov A. Lomakin, Arthur O. Zalevsky, Leyla A. Ovchinnikova, Diana M. Malabuiok, Margarita N. Baranova et al. · 2026 · Nature Communications
  9. Broad Neutralizing Activity of Monoclonal Antibodies Against the Omicron Variants Isolated From Patients With Early Severe Acute Respiratory Syndrome Coronavirus‐2
    Da Sol Kim, Uijin Kim, Hye‐Min Woo, Hansaem Lee, Eun‐Seong Jo, Min Jeong Noh, So‐Young Lee, Byoung Kwon Park, Jeong‐Sun Yang, Kyung-Chang Kim et al. · 2026 · Journal of Medical Virology
  10. Generation and characterization of an anti ITGB4 monoclonal antibody that blocks Zika virus entry
    X D Han, Wenhui Li, Shuqian Yang, Yancun Gong, Jie Shen, Lei Song, Fang Wan, Guihua Wang, Haolong Cong · 2026 · Frontiers in Immunology
  11. Prophylaxis Strategies for SARS ‐ CoV ‐2 Infection in Adults With Hematological Malignancies in Saudi Arabia: Consensus Statements From the Working Group on COVID ‐19 Management in Hematological Malignancies
    Mubarak M. Al-Mansour, Ayman Alhejazi, Manal Ahmed Alsaggaf, Hafiz Mosa Malhan, Riad Omar El Fakih, Reyad Dada, Ghazi Alotaibi, Reem Saad Almaghrabi, Majid M. Alshamrani · 2026 · Cancer Reports